Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05894096Not ApplicableActive Not Recruiting

Air Cold Atmospheric Pressure Plasma Treatment for Acceleration of Venous Ulcer Healing

Role: collaborator

NCT04254237Not ApplicableCompleted

Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry

Role: lead

NCT04641767Completed

BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)

Role: collaborator

NCT04102397Not ApplicableCompleted

Subacromial Impingement Syndrome: Vojta Therapy vs Standard Treatment

Role: collaborator

All 4 trials loaded